Continuous Glucose Monitoring in Intensive Care Unit

Glucose control in ICU patients is challenging and exerts high burden on the nursing staff. Continuous glucose monitors (CGM) are now approved and widely available in the outpatient setting for patients with diabetes mellitus. However, only minimal evidence on CGM performance, reliability and benefit in achieving desired glucose control in the intensive care setting has been gathered so far. The objective of this study is to assess whether the use of CGM helps to maintain blood glucose levels within the time in range recommended for patients in the intensive care. In addition, accuracy of the sensor will be evaluated and compared to measurements of blood glucose by standardized biochemistry methods.

Inclusion Criteria: 1. Male or female patients, of 18 to 80 years of age, undergoing one of the following surgical procedures and post-operative care at ICU: 1. pancreas surgery - total or partial pancreas resection 2. orthotopic liver transplantation 3. simultaneous pancreas and kidney transplantation 4. patients with diabetes mellitus undergoing major surgery 2. Patient must have signed the Patient Informed Consent Form. Exclusion Criteria: Any criteria that would disable surgical procedures involved